Skip to content
value.today

Moxe Health Corp

Total raised
$35 M
2 rounds on record
Latest round
$30 M
May 2022
First round on record
Sep 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Moxe Health Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2022$30 MNo. 2$10 to $50 million

Moxe Health Corp: Raise no. 2, May 2022

Investors in this round

4 investors had bought by the notice of Jun 9, 2022: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Wilson · Executive Officer, Director
  • Michael Arce · Executive Officer
  • Michael Coyne · Executive Officer, Director
  • Christopher Lahoud · Director
  • Gary Kurtzman · Director
  • Kirk Nielsen · Director
  • Thomas Schnettler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel Wilson, Chief Executive Officer. Newest notice filed Jun 9, 2022. Read the notice at the SEC.

equitySEC
Sep 2016$5 MNo. 1$2 to $10 million

Moxe Health Corp: Raise no. 1, Sep 2016

Investors in this round

3 investors had bought by the notice of Oct 4, 2016: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Wilson · Executive Officer, Director
  • Gary J. Kurtzman, M.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dan Wilson, Chief Executive Officer. Newest notice filed Oct 4, 2016. Read the notice at the SEC.

equity, debtSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Moxe Health Corp chose not to state its revenue in its newest notice of a funding round (Jun 2022).

    SEC Form D · Jun 2022

  • The industry group it chose in its notices: Other.

    SEC Form D · Jun 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Moxe Health Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Moxe Health Corp
NameRoleNamed in
Daniel WilsonExecutive officerJun 2022
Michael ArceExecutive officerJun 2022
Michael CoyneExecutive officerJun 2022
Christopher LahoudDirectorJun 2022
Daniel WilsonDirectorJun 2022
Gary KurtzmanDirectorJun 2022
Kirk NielsenDirectorJun 2022
Michael CoyneDirectorJun 2022
Thomas SchnettlerDirectorJun 2022
Gary J. Kurtzman, M.D.DirectorOct 2016